We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Informed Consent Tool Aids Presurgical Assessment

By HospiMedica International staff writers
Posted on 05 Sep 2013
A new universal surgical risk calculator aids shared decision-making and informed consent for both patients and surgeons. More...


Researchers at the American College of Surgeons (ACS; Chicago, IL, USA) used standardized clinical data from 393 hospitals affiliated with the ACS Surgical Quality Improvement Program (NSQIP) to develop a web-based tool to allow surgeons to enter 21 preoperative factors, such as demographics, comorbidities, and procedure, and predict risk outcomes based on these factors; a universal model was compared to procedure-specific models, such as colorectal. To incorporate surgeon input, a subjective Surgeon Adjustment Score (SAS) allowing risk estimates to vary within a confidence interval was introduced and tested among 80 surgeons using 10 case scenarios.

The result, based on 1,414,006 patients encompassing 1,557 unique current procedural terminology (CPT) codes, is a universal surgical risk calculator model with excellent performance for mortality, morbidity, and six additional complications. Predictions were similarly robust for the universal calculator as for the procedure-specific calculators. SAS scores showed that surgeons demonstrated considerable agreement on the case scenario scoring, suggesting reliable score assignment between surgeons. The study describing the surgical risk calculator was published on July 17, 2013, in the Journal of the American College of Surgeons.

“The ACS NSQIP Surgical Risk Calculator is a decision-support tool based on reliable multi-institutional clinical data which can be used to estimate the risks of most operations,” concluded lead author Karl Bilimoria, MD, and colleagues of the ACS. “It will allow clinicians and patients to make decisions using empirically derived, patient-specific postoperative risks.”

According to the researchers, The US Centers for Medicare and Medicaid Services (CMS; Baltimore, MD, USA) may soon put forth a measure requiring US surgeons to provide patients with patient-specific, empirically derived estimates of postoperative complications.

Related Links:
American College of Surgeons
US Centers for Medicare and Medicaid Services
ACS NSQIP Surgical Risk Calculator webpage


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.